SMTL ID : 4leo.1

Crystal structure of anti-HER3 Fab RG7116 in complex with the extracellular domains of human Her3 (ERBB3)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.64 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain C: H.386, M.387, H.388, N.389 No protein-ligand interaction detected (PLIP)

5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 10 residues within 4Å: Chain C: R.62, E.63, C.224, F.225, A.226, C.227, N.231, S.233, G.234, C.236 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:R.62, C:N.231, C:G.234 NAG.3: 2 residues within 4Å: Chain C: V.333, N.334 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:V.333 Hydrogen bonds: C:N.334 NAG.4: 5 residues within 4Å: Chain C: L.307, R.369, S.394, N.395, R.425 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:R.369, C:S.394, C:N.395 Water bridges: C:N.395, C:N.395 NAG.5: 5 residues within 4Å: Chain C: P.385, H.388, L.417, N.418, Q.442 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:L.417 Hydrogen bonds: C:Q.442 NAG.6: 2 residues within 4Å: Chain C: E.596, N.597 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:E.596 Water bridges: C:N.597

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mirschberger, C. et al., RG7116, a Therapeutic Antibody That Binds the Inactive HER3 Receptor and Is Optimized for Immune Effector Activation. Cancer Res. (2013)

Release Date

2013-07-10

Peptides

RG7116 Fab heavy chain: A
RG7116 Fab light chain: B
Receptor tyrosine-protein kinase erbB-3: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

RG7116 Fab heavy chain

RG7116 Fab light chain

Receptor tyrosine-protein kinase erbB-3